Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Cancer Pain × Lidocaine × Clear all

Phase

Phase NA 1 Phase EARLY_PHASE1 1 Phase 3 1 Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 3 Neoplasms 2 Tuberculosis 1 Stomatitis 1 Sarcoidosis 1 Prostatic Neoplasms 1 Pain, Postoperative 1 Mucositis 1 Lung Neoplasms 1 Lung Diseases, Interstitial 1 Liver Neoplasms 1 Cough 1 Cancer Pain 1 Agnosia 1

Interventions

Water 1 Venlafaxine Hydrochloride 1 Methadone 1 Memantine 1 Lidocaine 1 Glucose 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01384877 2019-07-12

Subcutaneous Lidocaine For Cancer-Related Pain

British Columbia Cancer Agency

Phase 2/3 Completed

33 enrolled 16 charts

Cancer Pain, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡